ATE478068T1 - 4h-1,2,4-triazin-5-on-derivate, ihre herstellung und ihre verwendung als alpha-7-nikotin- acetylcholin-rezeptoren - Google Patents
4h-1,2,4-triazin-5-on-derivate, ihre herstellung und ihre verwendung als alpha-7-nikotin- acetylcholin-rezeptorenInfo
- Publication number
- ATE478068T1 ATE478068T1 AT06755440T AT06755440T ATE478068T1 AT E478068 T1 ATE478068 T1 AT E478068T1 AT 06755440 T AT06755440 T AT 06755440T AT 06755440 T AT06755440 T AT 06755440T AT E478068 T1 ATE478068 T1 AT E478068T1
- Authority
- AT
- Austria
- Prior art keywords
- nicotine
- triazine
- alpha
- derivatives
- preparation
- Prior art date
Links
- BFNNILAMSKQDRN-UHFFFAOYSA-N 2h-1,2,4-triazin-5-one Chemical class O=C1C=NNC=N1 BFNNILAMSKQDRN-UHFFFAOYSA-N 0.000 title 1
- 229960004373 acetylcholine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0504042A FR2884822B1 (fr) | 2005-04-22 | 2005-04-22 | Derives de triazines, leur preparation et leur application en therapeutique |
| PCT/FR2006/000887 WO2006111662A2 (fr) | 2005-04-22 | 2006-04-21 | Derives de 4h-1 , 2 , 4-triazin-5-0nes , leur preparation et leur utilisation comme des recepteurs a l'acetylcholine de type nicotiniques alpha7 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE478068T1 true ATE478068T1 (de) | 2010-09-15 |
Family
ID=35219499
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06755440T ATE478068T1 (de) | 2005-04-22 | 2006-04-21 | 4h-1,2,4-triazin-5-on-derivate, ihre herstellung und ihre verwendung als alpha-7-nikotin- acetylcholin-rezeptoren |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7517881B2 (de) |
| EP (1) | EP1874761B1 (de) |
| JP (1) | JP4966295B2 (de) |
| AR (1) | AR054033A1 (de) |
| AT (1) | ATE478068T1 (de) |
| CY (1) | CY1111288T1 (de) |
| DE (1) | DE602006016258D1 (de) |
| DK (1) | DK1874761T3 (de) |
| ES (1) | ES2350950T3 (de) |
| FR (1) | FR2884822B1 (de) |
| HR (1) | HRP20100604T1 (de) |
| PL (1) | PL1874761T3 (de) |
| PT (1) | PT1874761E (de) |
| RS (1) | RS51557B (de) |
| SI (1) | SI1874761T1 (de) |
| TW (1) | TW200708506A (de) |
| WO (1) | WO2006111662A2 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0220581D0 (en) | 2002-09-04 | 2002-10-09 | Novartis Ag | Organic Compound |
| PE20060437A1 (es) | 2004-06-18 | 2006-06-08 | Novartis Ag | COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR |
| GB0415746D0 (en) | 2004-07-14 | 2004-08-18 | Novartis Ag | Organic compounds |
| GB0521508D0 (en) | 2005-10-21 | 2005-11-30 | Novartis Ag | Organic compounds |
| GB0525672D0 (en) | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
| GB0525673D0 (en) | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
| JO3250B1 (ar) | 2009-09-22 | 2018-09-16 | Novartis Ag | إستعمال منشطات مستقبل نيكوتينيك أسيتيل كولين ألفا 7 |
| IL262957B2 (en) * | 2016-05-12 | 2024-04-01 | Buck Inst Res Aging | 6-Fluorotropistrone and a pharmaceutical formulation comprising it for the relief of amyloid-related diseases |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4774604B2 (ja) * | 2000-02-14 | 2011-09-14 | 和光純薬工業株式会社 | 第４級アンモニウム塩の製造方法 |
| JP4616971B2 (ja) * | 2000-07-18 | 2011-01-19 | 田辺三菱製薬株式会社 | １−アザビシクロアルカン化合物およびその医薬用途 |
| HUP0402289A2 (hu) * | 2001-10-02 | 2005-02-28 | Pharmacia & Upjohn Company | Gyógyhatású azabiciklusos csoporttal helyettesített kondenzált heteroaril-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk |
| SE0301320D0 (sv) * | 2003-05-06 | 2003-05-06 | Astrazeneca Ab | Positive modulators of nicotinic acetylcholine receptors |
-
2005
- 2005-04-22 FR FR0504042A patent/FR2884822B1/fr not_active Expired - Fee Related
-
2006
- 2006-04-20 AR ARP060101561A patent/AR054033A1/es unknown
- 2006-04-21 EP EP06755440A patent/EP1874761B1/de not_active Expired - Lifetime
- 2006-04-21 PL PL06755440T patent/PL1874761T3/pl unknown
- 2006-04-21 PT PT06755440T patent/PT1874761E/pt unknown
- 2006-04-21 DE DE602006016258T patent/DE602006016258D1/de not_active Expired - Lifetime
- 2006-04-21 ES ES06755440T patent/ES2350950T3/es not_active Expired - Lifetime
- 2006-04-21 WO PCT/FR2006/000887 patent/WO2006111662A2/fr not_active Ceased
- 2006-04-21 TW TW095114225A patent/TW200708506A/zh unknown
- 2006-04-21 JP JP2008507128A patent/JP4966295B2/ja not_active Expired - Fee Related
- 2006-04-21 HR HR20100604T patent/HRP20100604T1/hr unknown
- 2006-04-21 DK DK06755440.2T patent/DK1874761T3/da active
- 2006-04-21 RS RSP-2010/0487A patent/RS51557B/sr unknown
- 2006-04-21 AT AT06755440T patent/ATE478068T1/de active
- 2006-04-21 SI SI200630825T patent/SI1874761T1/sl unknown
-
2007
- 2007-10-09 US US11/869,260 patent/US7517881B2/en not_active Expired - Fee Related
-
2010
- 2010-11-12 CY CY20101101023T patent/CY1111288T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI1874761T1 (sl) | 2010-12-31 |
| EP1874761B1 (de) | 2010-08-18 |
| JP4966295B2 (ja) | 2012-07-04 |
| JP2008536902A (ja) | 2008-09-11 |
| FR2884822B1 (fr) | 2007-06-29 |
| PL1874761T3 (pl) | 2011-02-28 |
| FR2884822A1 (fr) | 2006-10-27 |
| HRP20100604T1 (hr) | 2010-12-31 |
| DK1874761T3 (da) | 2010-12-13 |
| PT1874761E (pt) | 2010-11-18 |
| ES2350950T3 (es) | 2011-01-28 |
| RS51557B (sr) | 2011-06-30 |
| CY1111288T1 (el) | 2015-08-05 |
| US20080096891A1 (en) | 2008-04-24 |
| AR054033A1 (es) | 2007-05-30 |
| WO2006111662A3 (fr) | 2006-11-30 |
| DE602006016258D1 (de) | 2010-09-30 |
| WO2006111662A2 (fr) | 2006-10-26 |
| EP1874761A2 (de) | 2008-01-09 |
| TW200708506A (en) | 2007-03-01 |
| US7517881B2 (en) | 2009-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE543808T1 (de) | 5,6-ring-annelierte indolderivate und ihre verwendung | |
| ATE494290T1 (de) | Substituierte 2,5-dihydro-3h-pyrazol-ä4,3-cü- pyridazin-3-on-derivate, ihre herstellung und ihre verwendung als cannibinoid-cb1- rezeptorliganden | |
| EP2030974A4 (de) | Heterozyklische nichtnukleosidverbindungen, ihre herstellung, pharmazeutische zusammensetzung und ihre verwendung als antivirale mittel | |
| ATE467633T1 (de) | 2-aryl-6-phenylimidazoä1,2-aüpyridin-derivate, ihre herstellung und therapeutische verwendung | |
| DE50311318D1 (de) | Neue substituierte imidazo-pyridinone und imidazo-pyridazinone, ihre herstellung und ihre verwendung als arzneimittel | |
| DE502005007196D1 (de) | 8-ä3-amino-piperidin-1-ylü-xanthine, deren herstellung und deren verwendung als dpp-iv hemmer | |
| ATE520686T1 (de) | Azabicycloä3.1.0ühexanderivate und ihre verwendung als modulatoren des dopamin-d3- rezeptors | |
| DE602006013878D1 (de) | Heterocyclische verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel | |
| DE502005006424D1 (de) | Neue alkyl-haltige 5-acylindolinone, deren herstellung und deren verwendung als arzneimittel | |
| ATE432701T1 (de) | Indol-6-sulfonamid-derivate, ihre herstellung und ihre verwendung als 5-ht-6 modulatoren | |
| DE602004010426D1 (de) | Mikrobizide zusammensetzungen und ihre verwendung | |
| DE602005011593D1 (de) | Substituierte diazaspiroä5.5üundecanderivate und deren verwendung als neurokininantagonisten | |
| DK1869056T3 (da) | Nye 5-substituerede 7-amino-[1,3]thiazolo[4,5-D]pyrimidin-derivater | |
| ATE502035T1 (de) | 2-amido-4-phenylthiazol-derivate, ihre herstellung und ihre therapeutische verwendung | |
| ATE518834T1 (de) | 2,3,4,9-tetrahydro-1h-carbazol-derivative als crth2-rezeptorantagonisten | |
| DE602004021384D1 (de) | Indol-5 -sulfonamid-derivate, ihre herstellung und verwendung als 5-ht-6 modulatoren | |
| DE602005019743D1 (de) | Oxopiperidinderivate, ihre herstellung und therapeutische verwendung | |
| ATE396994T1 (de) | 3-phenylpyridoindolderivate, ihre herstellung und verwendung | |
| DE602004015600D1 (de) | Neue imidazolderivative, deren herstellung und deren verwendung als medikament | |
| ATE451923T1 (de) | N-(arylalkyl)-1h-pyrrolopyridin-2-carboxamid- derivate, ihre herstellung und verwendung | |
| ATE478068T1 (de) | 4h-1,2,4-triazin-5-on-derivate, ihre herstellung und ihre verwendung als alpha-7-nikotin- acetylcholin-rezeptoren | |
| EP1968616A4 (de) | Sulindac-derivate, ihre verwendung und herstellung | |
| ATE542806T1 (de) | Diarylmethylpiperazinderivate, deren herstellung und deren verwendung | |
| ATE484503T1 (de) | 2-pyrrolidin-2-yl-ä1,3,4ü -oxadiazol-derivate und ihre verwendung als antidepressiva | |
| DE602006002887D1 (de) | Tricyclische azolderivate, ihre herstellung und ihre verwendung als pharmazeutische mittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1874761 Country of ref document: EP |